354 related articles for article (PubMed ID: 27920472)
1. Anti-inflammatory effect of cannabinoid agonist WIN55, 212 on mouse experimental colitis is related to inhibition of p38MAPK.
Feng YJ; Li YY; Lin XH; Li K; Cao MH
World J Gastroenterol; 2016 Nov; 22(43):9515-9524. PubMed ID: 27920472
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of p38/Mk2 signaling pathway improves the anti-inflammatory effect of WIN55 on mouse experimental colitis.
Li YY; Yuece B; Cao HM; Lin HX; Lv S; Chen JC; Ochs S; Sibaev A; Deindl E; Schaefer C; Storr M
Lab Invest; 2013 Mar; 93(3):322-33. PubMed ID: 23381627
[TBL] [Abstract][Full Text] [Related]
3. Involvement of the CB
Khan MI; Sobocińska AA; Brodaczewska KK; Zielniok K; Gajewska M; Kieda C; Czarnecka AM; Szczylik C
BMC Cancer; 2018 May; 18(1):583. PubMed ID: 29792186
[TBL] [Abstract][Full Text] [Related]
4. Activation of cannabinoid receptor 2 reduces inflammation in acute experimental pancreatitis via intra-acinar activation of p38 and MK2-dependent mechanisms.
Michler T; Storr M; Kramer J; Ochs S; Malo A; Reu S; Göke B; Schäfer C
Am J Physiol Gastrointest Liver Physiol; 2013 Jan; 304(2):G181-92. PubMed ID: 23139224
[TBL] [Abstract][Full Text] [Related]
5. FR167653, a p38 mitogen-activated protein kinase inhibitor, aggravates experimental colitis in mice.
Nishimura T; Andoh A; Nishida A; Shioya M; Koizumi Y; Tsujikawa T; Fujiyama Y
World J Gastroenterol; 2008 Oct; 14(38):5851-6. PubMed ID: 18855984
[TBL] [Abstract][Full Text] [Related]
6. Naphthalen-1-yl-(4-pentyloxynaphthalen-1-yl)methanone (SAB378), a peripherally restricted cannabinoid CB1/CB2 receptor agonist, inhibits gastrointestinal motility but has no effect on experimental colitis in mice.
Cluny NL; Keenan CM; Duncan M; Fox A; Lutz B; Sharkey KA
J Pharmacol Exp Ther; 2010 Sep; 334(3):973-80. PubMed ID: 20571060
[TBL] [Abstract][Full Text] [Related]
7. [Role of p38 mitogen-activated protein kinase pathway in pathogenesis of ulcerative colitis].
He FQ; Zou YP; Huang XL; Gao FJ; Peng L; Gan HT
Sichuan Da Xue Xue Bao Yi Xue Ban; 2013 May; 44(3):393-6, 401. PubMed ID: 23898520
[TBL] [Abstract][Full Text] [Related]
8. β-Caryophyllene inhibits dextran sulfate sodium-induced colitis in mice through CB2 receptor activation and PPARγ pathway.
Bento AF; Marcon R; Dutra RC; Claudino RF; Cola M; Leite DF; Calixto JB
Am J Pathol; 2011 Mar; 178(3):1153-66. PubMed ID: 21356367
[TBL] [Abstract][Full Text] [Related]
9. Effect of acute and subchronic administration of (R)-WIN55,212-2 induced neuroprotection and anti inflammatory actions in rat retina: CB1 and CB2 receptor involvement.
Spyridakos D; Papadogkonaki S; Dionysopoulou S; Mastrodimou N; Polioudaki H; Thermos K
Neurochem Int; 2021 Jan; 142():104907. PubMed ID: 33220388
[TBL] [Abstract][Full Text] [Related]
10. TLR4 monoclonal antibody blockade suppresses dextran-sulfate-sodium-induced colitis in mice.
Liu Y; Zhang Z; Wang L; Li J; Dong L; Yue W; Chen J; Sun X; Zhong L; Sun D
J Gastroenterol Hepatol; 2010 Jan; 25(1):209-14. PubMed ID: 19929926
[TBL] [Abstract][Full Text] [Related]
11. Cannabinoids ameliorate disease progression in a model of multiple sclerosis in mice, acting preferentially through CB1 receptor-mediated anti-inflammatory effects.
de Lago E; Moreno-Martet M; Cabranes A; Ramos JA; Fernández-Ruiz J
Neuropharmacology; 2012 Jun; 62(7):2299-308. PubMed ID: 22342378
[TBL] [Abstract][Full Text] [Related]
12. Agonists of cannabinoid receptor 1 and 2 inhibit experimental colitis induced by oil of mustard and by dextran sulfate sodium.
Kimball ES; Schneider CR; Wallace NH; Hornby PJ
Am J Physiol Gastrointest Liver Physiol; 2006 Aug; 291(2):G364-71. PubMed ID: 16574988
[TBL] [Abstract][Full Text] [Related]
13. Inhibitory effect of synthetic cannabinoids on cytokine production in rheumatoid fibroblast-like synoviocytes.
Selvi E; Lorenzini S; Garcia-Gonzalez E; Maggio R; Lazzerini PE; Capecchi PL; Balistreri E; Spreafico A; Niccolini S; Pompella G; Natale MR; Guideri F; Laghi Pasini F; Galeazzi M; Marcolongo R
Clin Exp Rheumatol; 2008; 26(4):574-81. PubMed ID: 18799087
[TBL] [Abstract][Full Text] [Related]
14. Cannabinoid CB
Olianas MC; Dedoni S; Onali P
Life Sci; 2021 Jul; 276():119407. PubMed ID: 33794254
[TBL] [Abstract][Full Text] [Related]
15. WIN55,212-2 inhibits production of CX3CL1 by human astrocytes: involvement of p38 MAP kinase.
Sheng WS; Hu S; Ni HT; Rock RB; Peterson PK
J Neuroimmune Pharmacol; 2009 Jun; 4(2):244-8. PubMed ID: 19214751
[TBL] [Abstract][Full Text] [Related]
16. WIN55,212-2-mediated inhibition of HIV-1 expression in microglial cells: involvement of cannabinoid receptors.
Rock RB; Gekker G; Hu S; Sheng WS; Cabral GA; Martin BR; Peterson PK
J Neuroimmune Pharmacol; 2007 Jun; 2(2):178-83. PubMed ID: 18040842
[TBL] [Abstract][Full Text] [Related]
17. Activation of cannabinoid CB1 and CB2 receptors suppresses neuropathic nociception evoked by the chemotherapeutic agent vincristine in rats.
Rahn EJ; Makriyannis A; Hohmann AG
Br J Pharmacol; 2007 Nov; 152(5):765-77. PubMed ID: 17572696
[TBL] [Abstract][Full Text] [Related]
18. Blockade of dorsal hippocampal dopamine receptors inhibits state-dependent learning induced by cannabinoid receptor agonist in mice.
Zarrindast MR; Dorrani M; Lachinani R; Rezayof A
Neurosci Res; 2010 May; 67(1):25-32. PubMed ID: 20144666
[TBL] [Abstract][Full Text] [Related]
19. Zhikang Capsule ameliorates dextran sodium sulfate-induced colitis by inhibition of inflammation, apoptosis, oxidative stress and MyD88-dependent TLR4 signaling pathway.
Fei L; Xu K
J Ethnopharmacol; 2016 Nov; 192():236-247. PubMed ID: 27452656
[TBL] [Abstract][Full Text] [Related]
20. Cannabidiol displays unexpectedly high potency as an antagonist of CB1 and CB2 receptor agonists in vitro.
Thomas A; Baillie GL; Phillips AM; Razdan RK; Ross RA; Pertwee RG
Br J Pharmacol; 2007 Mar; 150(5):613-23. PubMed ID: 17245363
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
